Compare BWAY & BHK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | BWAY | BHK |
|---|---|---|
| Founded | 2003 | 2001 |
| Country | Israel | United States |
| Employees | N/A | N/A |
| Industry | Medical/Dental Instruments | Finance Companies |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 578.5M | 655.1M |
| IPO Year | 2011 | N/A |
| Metric | BWAY | BHK |
|---|---|---|
| Price | $14.18 | $8.94 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 2 | 0 |
| Target Price | ★ $13.25 | N/A |
| AVG Volume (30 Days) | 108.7K | ★ 234.5K |
| Earning Date | 05-13-2026 | 01-01-0001 |
| Dividend Yield | N/A | ★ 8.34% |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ 1.03 |
| Revenue | N/A | N/A |
| Revenue This Year | $309.69 | N/A |
| Revenue Next Year | $26.21 | N/A |
| P/E Ratio | $81.98 | ★ $8.69 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $11.77 | $8.69 |
| 52 Week High | $26.63 | $10.12 |
| Indicator | BWAY | BHK |
|---|---|---|
| Relative Strength Index (RSI) | 44.67 | 45.25 |
| Support Level | $14.08 | $8.86 |
| Resistance Level | $14.85 | $9.05 |
| Average True Range (ATR) | 0.53 | 0.09 |
| MACD | -0.06 | -0.01 |
| Stochastic Oscillator | 19.25 | 27.45 |
BrainsWay Ltd is engaged in advanced noninvasive neurostimulation treatments for mental health disorders. The company is advancing neuroscience with its proprietary Deep Transcranial Magnetic Stimulation (Deep TMS) platform technology to improve health and transform lives. Current indications include depressive disorder (including reduction of anxiety symptoms, commonly referred to as anxious depression), obsessive-compulsive disorder, and smoking addiction. Additional clinical trials of Deep TMS in various psychiatric, neurological, and addiction disorders are underway. The company derives revenues from the lease and sale of Deep TMS systems.
Blackrock Core Bond Trust is a closed-ended management investment company. Its objective is to provide current income and capital appreciation. The trust seeks to achieve its investment objective by investing, under normal market conditions, at least 75% of its managed assets in bonds that are investment-grade quality at the time of investment. The trust, under a normal market scenario, will invest in a range of bonds, including corporate bonds, U.S. government and agency securities, and mortgage-related securities.